Medical News Today

Repatha vs. Praluent

Both Repatha and Praluent are used to treat high cholesterol and reduce the risk of certain cardiovascular events. The drugs also have different approved uses in adults and children. Repatha and ...
Medical News Today

Praluent side effects: What you should know

Praluent (alirocumab) is a brand-name drug that’s prescribed to lower high cholesterol levels and the risk of certain heart problems in adults. As with other drugs, Praluent can cause side effects, ...
FiercePharma

Sanofi and Regeneron Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

- Praluent will be available in both a 75 mg and 150 mg dose for self-administration every two weeks - Paris and Tarrytown, New York - September 28, 2015 - Sanofi and Regeneron Pharmaceuticals, Inc.
TCTMD

Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection

TARRYTOWN, N.Y. and PARIS, Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent ® (alirocumab) Injection met its ...